Skip to main content
. 2013 Oct 31;99(1):E137–E142. doi: 10.1210/jc.2013-2951

Figure 1.

Figure 1.

TgAbs and TPOAbs in patients treated with anatabine (○) or placebo (●). A and B, means ± SEM over time for TgAbs and TPOAbs. C, Absolute change in TgAbs between subsequent visits and baseline. D, Percentage of patients with a >20% decrease in TgAbs.